Biohit Oyj operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biohit Oyj with three other
pharmaceutical manufacturers in Europe:
RTA Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret AS
sales of 33.96 million Turkish Liras [US$8.79 million]
IDL Biotech AB
(28.52 million Swedish Kronor [US$3.16 million]
based in Germany
(2.08 million Euro [US$2.20 million]
of which 75%
was Product sales (own and third party)).
Biohit Oyj reported sales of 6.05 million Euro (US$6.40 million)
December of 2015.
increase of 38.7%
versus 2014, when the company's sales were 4.36 million Euro.
This was the third consecutive year of growth at Biohit Oyj.